Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

[Effect of transcription factor E2F1 expression on the invasion of prostate cancer].

Bi XC, Pu XY, Liu JM, Huang S.

Zhonghua Yi Xue Za Zhi. 2017 Sep 26;97(36):2856-2859. doi: 10.3760/cma.j.issn.0376-2491.2017.36.016. Chinese.

PMID:
29050152
2.

[Comparison of laparoscopic pyelolithotomy and percutaneous nephrolithotomy for renal pelvic stones larger than 2.5 cm].

Pu XY, Liu JM, Bi XC, Li D, Huang S, Feng YH, Lin CQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb 20;37(2):251-255. Chinese.

PMID:
28219872
3.

CC chemokine ligand 18 correlates with malignant progression of prostate cancer.

Chen G, Liang YX, Zhu JG, Fu X, Chen YF, Mo RJ, Zhou L, Fu H, Bi XC, He HC, Yang SB, Wu YD, Jiang FN, Zhong WD.

Biomed Res Int. 2014;2014:230183. doi: 10.1155/2014/230183. Epub 2014 Aug 17.

4.

Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.

Huang YQ, Han ZD, Liang YX, Lin ZY, Ling XH, Fu X, Cai C, Bi XC, Dai QS, Chen JH, He HC, Chen YR, Jiang FN, Zhong WD.

Med Oncol. 2014 Jan;31(1):820. doi: 10.1007/s12032-013-0820-4. Epub 2013 Dec 14.

PMID:
24338276
5.

[Case-control study on the correlation of bladder cancer incidence and occupational factors].

He GN, Zhong WD, Bi XC, Hu ZQ, Zhong CH, Xie LP, He HC, Han ZD, Ye ZQ.

Zhonghua Yi Xue Za Zhi. 2012 Jul 24;92(28):1978-80. Chinese.

PMID:
22944273
6.

[Effects of PPAR-gamma on the proliferation and glycolysis metabolism of prostate cancer cells].

Zeng XJ, Bi XC, Dai QS, Han ZD, Zhong WD.

Zhonghua Nan Ke Xue. 2012 Aug;18(8):692-6. Chinese.

PMID:
22934513
7.

Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.

Bi XC, Liu JM, He HC, Ye YK, Han ZD, Dai QS, Liang YX, Cai C, Chen JH, Chen XB, Qin GQ, Zeng GH, Zhong WD.

Clin Transl Oncol. 2012 Mar;14(3):190-6.

PMID:
22374422
8.

Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.

Chen XS, Zhang ZT, Du J, Bi XC, Sun G, Yao X.

Urology. 2012 Apr;79(4):836-9. doi: 10.1016/j.urology.2011.11.023. Epub 2012 Feb 2.

PMID:
22305422
9.

Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.

Han ZD, Zhang YQ, He HC, Dai QS, Qin GQ, Chen JH, Cai C, Fu X, Bi XC, Zhu JG, Liao DJ, Lu XP, Mo ZY, Zhu YP, Zhong WD.

Med Oncol. 2012 Dec;29(4):2877-88. doi: 10.1007/s12032-011-0149-9. Epub 2012 Jan 4.

PMID:
22215415
10.
11.

Expression of CD147 is associated with prostate cancer progression.

Zhong WD, Liang YX, Lin SX, Li L, He HC, Bi XC, Han ZD, Dai QS, Ye YK, Chen QB, Wang YS, Zeng GH, Zhu G, Zhang Z, Chen ZN, Wu CL.

Int J Cancer. 2012 Jan 15;130(2):300-8. doi: 10.1002/ijc.25982. Epub 2011 Apr 27.

12.

Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.

Zhong WD, Chen QB, Ye YK, Han ZD, Bi XC, Dai QS, Liang YX, Zeng GH, Wang YS, Zhu G, Chen ZN, He HC.

Cancer Epidemiol. 2010 Aug;34(4):478-82. doi: 10.1016/j.canep.2010.04.007. Epub 2010 May 18.

PMID:
20483678
13.

Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in children.

Bi XC, Zhang B, Ye YK, He HC, Han ZD, Dai QS, Liang YX, Zeng GH, Wang YS, Chen QB, Zhong WD.

J Chemother. 2009 Dec;21(6):661-5.

PMID:
20071290
14.

CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma.

Ye YK, Bi XC, He HC, Han ZD, Dai QS, Liang YX, Zeng GH, Qin WJ, Chen ZN, Zhong WD.

Clin Exp Med. 2010 Sep;10(3):153-8. doi: 10.1007/s10238-009-0088-3. Epub 2010 Jan 13.

PMID:
20069333
15.

Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.

Zhu G, Yan W, He HC, Bi XC, Han ZD, Dai QS, Ye YK, Liang YX, Wang J, Zhong W.

Mol Med. 2009 Nov-Dec;15(11-12):363-70. doi: 10.2119/molmed.2009.00082. Epub 2009 Aug 18.

16.

CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.

Liang YX, He HC, Han ZD, Bi XC, Dai QS, Ye YK, Qin WJ, Zeng GH, Zhu G, Xu CL, Zhong WD.

Cancer Invest. 2009 Aug;27(7):788-93. doi: 10.1080/07357900802709167.

PMID:
19548138
17.

Expression and clinical significance of CD147 in genitourinary carcinomas.

Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD.

J Surg Res. 2010 May 15;160(2):260-7. doi: 10.1016/j.jss.2008.11.838. Epub 2008 Dec 10.

PMID:
19286191
18.

CD147 expression indicates unfavourable prognosis in prostate cancer.

Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Chen ZN, Zhong WD.

Pathol Oncol Res. 2009 Sep;15(3):369-74. doi: 10.1007/s12253-008-9131-z.

PMID:
19048397
19.

Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.

He HC, Bi XC, Zheng ZW, Dai QS, Han ZD, Liang YX, Ye YK, Zeng GH, Zhu G, Zhong WD.

Med Oncol. 2009;26(3):303-8. doi: 10.1007/s12032-008-9120-9. Epub 2008 Nov 12.

PMID:
19003546
20.

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN.

Oncology. 2008;75(3-4):230-6. doi: 10.1159/000163852. Epub 2008 Oct 14.

PMID:
18852494

Supplemental Content

Support Center